+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

How much do we understand about pharmacotherapy of cardiac arrhythmias?



How much do we understand about pharmacotherapy of cardiac arrhythmias?



Lijecnicki Vjesnik 115(5-6): 156-159



By an anonymous, multiple-choice questionnaire assessed was the knowledge of cardiac electrophysiology and mechanism of action of some antiarrhythmic drugs among the staff members of a department of medicine from a large regional hospital. The overall results were disappointing (over 55 per cent of inaccurate answers), but improved after 3 months (less than 30 per cent). It is concluded that such a polling increases the level of awareness about target problem (cardiac arrhythmia management in the actual case) and improves the performance of health professionals.

(PDF emailed within 1 workday: $29.90)

Accession: 046280122

Download citation: RISBibTeXText

PMID: 8302137


Related references

Basis of pharmacotherapy of cardiac arrhythmias. Modern Concepts of Cardiovascular Disease 31: 739-744, 1962

Guidelines for Non-Pharmacotherapy of Cardiac Arrhythmias (JCS 2011). Circulation Journal 77(1): 249-274, 2013

Pharmacotherapy of cardiac arrhythmias in women--what do we know, do we have a choice?. Przeglad Lekarski 71(3): 155-159, 2014

Computational approaches to understand cardiac electrophysiology and arrhythmias. American Journal of Physiology. Heart and Circulatory Physiology 303(7): H766-H783, 2012

Neuropsychiatric sequelae of pharmacotherapy of cardiac arrhythmias and hypertension. Journal of Clinical Psychopharmacology 1(6): 394-398, 1981

Pharmacotherapy of cardiac arrhythmias--basic science for clinicians. Pacing and Clinical Electrophysiology 32(11): 1454-1465, 2010

Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction. Folia Medica Neerlandica 14(5): 225-236, 1971

Do we understand the electrophysiologic mechanisms responsible for drug-induced cardiac arrhythmias?. Journal of Cardiovascular Pharmacology 40(5): 647-650, 2002

Possibilities and trends of pharmacotherapy of cardiac arrhythmias in childhood and adolescence. 1: General principles, clinical aspects and indications. Zeitschrift für Arztliche Fortbildung 82(5): 205-208, 1988

Resuscitation great. Paul M. Zoll, M.D.-- the father of "modern" electrotherapy and innovator of pharmacotherapy for life-threatening cardiac arrhythmias. Resuscitation 73(2): 178-185, 2007

Possibilities and trends of pharmacotherapy of cardiac arrhythmias in childhood and adolescence. 3: Determinative criteria, therapeutic concept and selection of drugs. Zeitschrift für Arztliche Fortbildung 82(7): 305-309, 1988

Clinical analysis of cardiac arrhythmias in patients with chronic renal failure treated conservatively. I. Evaluation of cardiac arrhythmias. Polskie Archiwum Medycyny Wewnetrznej 90(6): 438-444, 1993

Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias. A Automaticity. American Heart Journal 88(4): 515-524, 1974

Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias B. Re-entry. Section I. American Heart Journal 88(5): 664-670, 1974

Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias b. Re-entry. Section II. American Heart Journal 88(6): 798-806, 1974